product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
UCHL1 (D3T2E) XP Rabbit mAb
catalog :
13179
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D3T2E
reactivity :
human
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
  • western blot; human; loading ...; fig 1a
Shimada Y, Kudo Y, Maehara S, Matsubayashi J, Otaki Y, Kajiwara N, et al. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers. Cancer Sci. 2020;111:610-620 pubmed publisher
  • immunohistochemistry; human; loading ...; fig 6e
Kong X, Chen J, Xie W, Brown S, Cai Y, Wu K, et al. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. Cancer Cell. 2019;35:633-648.e7 pubmed publisher
Niedenberger B, Geyer C. Advanced immunostaining approaches to study early male germ cell development. Stem Cell Res. 2018;27:162-168 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.